Peroxisome proliferator-activated receptor-γagonist induces regulatory T cells in a murine model of allergic rhinitis

Otolaryngology - Head and Neck Surgery

Volumn 144, Issue 4, 2011, Pages 506-513

  Wang, Weihua ^a   Zhu, Zhenghua ^a   Zhu, Bingwei ^a   Ma, Zhaoxin ^a  

^a TONGJI UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Allergic rhinitis; Peroxisome proliferator activated receptor; Pioglitazone; Regulatory T lymphocyte

Indexed keywords

2 CHLORO 5 NITROBENZANILIDE; GAMMA INTERFERON; IMMUNOGLOBULIN E; INTERLEUKIN 5; MESSENGER RNA; OVALBUMIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA AGONIST; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA ANTAGONIST; PIOGLITAZONE; TRANSCRIPTION FACTOR FOXP3; TRANSCRIPTION FACTOR GATA 3; TRANSCRIPTION FACTOR T BET; 2,4 THIAZOLIDINEDIONE DERIVATIVE; 2-CHLORO-5-NITROBENZANILIDE; ANILIDE; FORKHEAD TRANSCRIPTION FACTOR; FOXP3 PROTEIN, MOUSE; GATA3 PROTEIN, MOUSE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; T BOX TRANSCRIPTION FACTOR; T BOX TRANSCRIPTION FACTOR TBX21; T-BOX TRANSCRIPTION FACTOR TBX21;

ALLERGIC REACTION; ALLERGIC RHINITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BAGG ALBINO MOUSE; CONTROLLED STUDY; DRUG MECHANISM; FEMALE; FLOW CYTOMETRY; MOUSE; NONHUMAN; REAL TIME POLYMERASE CHAIN REACTION; REGULATORY T LYMPHOCYTE; SCRATCHING; SNEEZING; ANIMAL; BLOOD; CHEMISTRY; CYTOLOGY; DRUG ANTAGONISM; DRUG POTENTIATION; IMMUNOLOGY; NOSE MUCOSA; NOSE MUCUS; PATHOLOGY; PATHOPHYSIOLOGY; PERENNIAL RHINITIS;

ANILIDES; ANIMALS; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; GATA3 TRANSCRIPTION FACTOR; IMMUNOGLOBULIN E; INTERFERON-GAMMA; INTERLEUKIN-5; MICE; MICE, INBRED BALB C; NASAL LAVAGE FLUID; NASAL MUCOSA; OVALBUMIN; PPAR GAMMA; RHINITIS, ALLERGIC, PERENNIAL; T-BOX DOMAIN PROTEINS; T-LYMPHOCYTES, REGULATORY; THIAZOLIDINEDIONES;

EID: 84863365905     PISSN: 01945998     EISSN: 10976817     Source Type: Journal    
DOI: 10.1177/0194599810396133     Document Type: Article

References (30)

1. Kota BP, Huang TH, Roufogalis BD. An overview on biological mechanisms of PPARs. Pharmacol Res. 2005;51:85-94. (Pubitemid 40040538)
2. Benayoun L, Letuve S, Druilhe A, et al. Regulation of peroxisome proliferator-activated receptor gamma expression in human asthmatic airways: relationship with proliferation, apoptosis, and airway remodeling. Am J Respir Crit Care Med. 2001;164:1487-1494. (Pubitemid 33124032)
3. Kang HJ, Cinn YG, Hwang SJ, et al. Up-regulation of peroxisome proliferator-activated receptor gamma in perennial allergic rhinitis. Arch Otolaryngol Head Neck Surg. 2006;132:1196-1200.
4. Jeon EJ, Lee SK, Park YS, Kim D-H, Yum JH, Park C-S. The effects of peroxisome proliferator-activated receptor-gamma agonist on a murine model of experimental allergic rhinitis. Otolaryngol Head Neck Surg. 2008;139:124-130. (Pubitemid 351862347)
5. Han JL, Ding RY, Zhao L, Ren Z, Jiang XJ. Rosiglitazone attenuates allergic inflammation and inhibits expression of galectin-3 in a mouse model of allergic rhinitis. J Int Med Res. 2008;36:830-836.
6. Zhang L, Han D, Huang D, et al. Prevalence of self-reported allergic rhinitis in eleven major cities in China. Int Arch Allergy Immunol. 2009;149:47-57.
7. Tang Q, Bluestone JA. The Foxp3+ regulatory T cell: a jack of all trades, master of regulation. Nat Immunol. 2008;9:239-244. (Pubitemid 351267321)
8. Belkaid Y, Rouse BT. Natural regulatory T cells in infectious disease. Nat Immunol. 2005;6:353-360. (Pubitemid 41716772)
9. Taylor PA, Noelle RJ, Blazar BR. CD4(+)CD25(+) immune regulatory cells are required for induction of tolerance to alloantigen via costimulatory blockade. J Exp Med. 2001;193:1311-1318.
10. Housley WJ, O'Conor CA, Nichols F, et al. PPARgamma regulates retinoic acid-mediated DC induction of Tregs. J Leukoc Biol. 2009;86:293-301.
11. Romagnani S. Immunologic influences on allergy and the TH1/ TH2 balance. J Allergy Clin Immunol. 2004;113:395-400. (Pubitemid 38338939)
12. Zheng W, Flavell RA. The transcription factor GATA-3 is necessary and sufficient for Th2 cytokine gene expression in CD4 T cells. Cell. 1997;89:587-596. (Pubitemid 27511769)
13. Szabo SJ, Kim ST, Costa GL, Zhang X, Fathman CG, Glimcher LH. A novel transcription factor, T-bet, directs Th1 lineage commitment. Cell. 2000;100:655-669.
14. Wohlfert EA, Nichols FC, Nevius E, et al. Peroxisome proliferator- activated receptor gamma (PPARgamma) and immunoregulation: enhancement of regulatory T cells through PPARgamma-dependent and -independent mechanisms. J Immunol. 2007;178:4129-4135. (Pubitemid 46492362)
15. Klotz L, Dani I, Edenhofer F, et al. Peroxisome proliferatoractivated receptor gamma control of dendritic cell function contributes to development of CD4+ T cell anergy. J Immunol. 2007;178:2122-2131. (Pubitemid 46233409)
16. Chinetti G, Fruchart JC, Staels B. Peroxisome proliferatoractivated receptors (PPARs): nuclear receptors at the crossroads between lipid metabolism and inflammation. Inflamm Res. 2000;49:497-505.
17. Clark RB. The role of PPARs in inflammation and immunity. J Leukoc Biol. 2002;71:388-400.
18. Clark RB, Bishop-Bailey D, Estrada-Hernandez T, Hla T, Puddington L, Padula SJ. The nuclear receptor PPAR gamma and immunoregulation: PPAR gamma mediates inhibition of helper T cell responses. J Immunol. 2000;164:1364-1371. (Pubitemid 30067250)
19. Delerive P, Fruchart JC, Staels B. Peroxisome proliferatoractivated receptors in inflammation control. J Endocrinol. 2001;169:453-459. (Pubitemid 32536978)
20. Natarajan C, Bright JJ. Peroxisome proliferator-activated receptor-gamma agonists inhibit experimental allergic encephalomyelitis by blocking IL-12 production, IL-12 signaling and Th1 differentiation. Genes Immun. 2002;3:59-70. (Pubitemid 38961111)
21. Daynes RA, Jones DC. Emerging roles of PPARs in inflammation and immunity. Nat Rev Immunol. 2002;2:748-759. (Pubitemid 37328715)
22. Ray DM, Akbiyik F, Bernstein SH, et al. CD40 engagement prevents peroxisome proliferator-activated receptor gamma agonist-induced apoptosis of B lymphocytes and B lymphoma cells by an NF-kappaB- dependent mechanism. J Immunol. 2005;174:4060-4069. (Pubitemid 40395982)
23. Lee KS, Park SJ, Hwang PH, et al. PPAR-gamma modulates allergic inflammation through up-regulation of PTEN. Faseb J. 2005;19:1033-1035. (Pubitemid 40827742)
24. Park SJ, Lee KS, Kim SR, et al. Peroxisome proliferatoractivated receptor gamma agonist down-regulates IL-17 expression in a murine model of allergic airway inflammation. J Immunol. 2009;183:3259-3267.
25. Yates A, Callard R, Stark J. Combining cytokine signalling with T-bet and GATA-3 regulation in Th1 and Th2 differentiation: a model for cellular decision-making. J Theor Biol. 2004;231: 181-196. (Pubitemid 39221871)
26. Lighvani AA, Frucht DM, Jankovic D, et al. T-bet is rapidly induced by interferon-gamma in lymphoid and myeloid cells. Proc Natl Acad Sci U S A. 2001;98:15137-15142. (Pubitemid 34013982)
27. Borish LC, Steinke JW. 2. Cytokines and chemokines. J Allergy Clin Immunol. 2003;111:S460-S475. (Pubitemid 36223285)
28. Xu G, Mou Z, Jiang H, et al. A possible role of CD4+CD25+ T cells as well as transcription factor Foxp3 in the dysregulation of allergic rhinitis. Laryngoscope. 2007;117:876-880. (Pubitemid 46699362)
29. Cosmi L, Liotta F, Angeli R, et al. Th2 cells are less susceptible than Th1 cells to the suppressive activity of CD25+ regulatory thymocytes because of their responsiveness to different cytokines. Blood. 2004;103:3117-3121. (Pubitemid 38451689)
30. Akahori T, Sho M, Hamada K, et al. Importance of peroxisome proliferator-activated receptor-gamma in hepatic ischemia/reperfusion injury in mice. J Hepatol. 2007;47:784-792. (Pubitemid 350051123)